Security Snapshot

Prestige Consumer Healthcare Inc. - Common Stock (PBH) Institutional Ownership

CUSIP: 74112D101

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

352

Shares (Excl. Options)

51,623,774

Price

$61.69

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
PBH on NYSE
Shares outstanding
48,264,671
Price per share
$59.27
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
51,623,774
Total reported value
$3,184,205,678
% of total 13F portfolios
0%
Share change
-608,102
Value change
-$39,122,211
Number of holders
352
Price from insider filings
$59.27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • PBH - Prestige Consumer Healthcare Inc. - Common Stock is tracked under CUSIP 74112D101.
  • 352 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 352 to 29 between Q4 2025 and Q1 2026.
  • Reported value moved from $3,184,205,678 to $61,111,205.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 352 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 74112D101?
CUSIP 74112D101 identifies PBH - Prestige Consumer Healthcare Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Prestige Consumer Healthcare Inc. - Common Stock (PBH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $609,115,318 7,524,587 BlackRock, Inc. 31 Mar 2025
ARIEL INVESTMENTS, LLC 8.5% +17% $251,154,866 +$31,071,476 4,102,497 +14% Ariel Investments, LLC 31 Dec 2025
DIMENSIONAL FUND ADVISORS LP 5.9% $235,326,993 2,907,066 Dimensional Fund Advisors LP 31 Dec 2024
MACQUARIE GROUP LTD 4.7% $186,914,926 2,309,017 Macquarie Group Limited 31 Dec 2024

As of 31 Dec 2025, 352 institutional investors reported holding 51,623,774 shares of Prestige Consumer Healthcare Inc. - Common Stock (PBH). This represents 107% of the company’s total 48,264,671 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Prestige Consumer Healthcare Inc. - Common Stock (PBH) together control 81% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 7,662,054 +0.91% 0.01% $472,672,093
VANGUARD GROUP INC 11% 5,388,758 -1.9% 0% $332,432,481
ARIEL INVESTMENTS, LLC 8.5% 4,102,497 +14% 2.7% $253,083,041
DIMENSIONAL FUND ADVISORS LP 5.3% 2,581,067 -0.41% 0.03% $159,227,818
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.4% 2,137,620 -3.4% 0.35% $131,869,778
STATE STREET CORP 4.1% 1,992,497 +1.4% 0% $122,917,140
Allspring Global Investments Holdings, LLC 3.3% 1,613,460 +1.3% 0.16% $98,776,022
GEODE CAPITAL MANAGEMENT, LLC 3% 1,431,561 -0.41% 0.01% $88,325,316
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 2.9% 1,421,966 0% 0.13% $87,721,000
MORGAN STANLEY 2.5% 1,202,927 +6.3% 0% $74,208,611
WESTWOOD HOLDINGS GROUP INC 2.4% 1,179,636 +3.3% 0.59% $72,771,745
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.5% 738,654 +5% 0.01% $45,567,565
NORTHERN TRUST CORP 1.5% 729,411 -2.4% 0.01% $44,997,365
Boston Trust Walden Corp 1.5% 713,772 -9.2% 0.33% $44,032,594
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.3% 650,793 +10% 0.01% $40,147,420
NORDEA INVESTMENT MANAGEMENT AB 1.3% 615,215 +547% 0.03% $37,811,114
RAYMOND JAMES FINANCIAL INC 1.3% 610,751 -4.3% 0.01% $37,915,875
BRANDES INVESTMENT PARTNERS, LP 1.3% 606,737 +93% 0.28% $37,429,606
NORGES BANK 1.2% 599,024 0% $36,953,791
Invesco Ltd. 1.2% 584,021 +7.5% 0.01% $36,028,255
BANK OF AMERICA CORP /DE/ 1.2% 566,026 -8% 0% $34,918,112
Capital Research Global Investors 1.2% 561,497 +108% 0.01% $34,638,750
PRICE T ROWE ASSOCIATES INC /MD/ 1.2% 558,476 +1.9% 0% $34,453,000
GOLDMAN SACHS GROUP INC 1.1% 526,627 -18% 0% $32,487,620
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1.1% 525,581 -16% 0.03% $32,423,092

Institutional Holders of Prestige Consumer Healthcare Inc. - Common Stock (PBH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,031,915 $61,111,205 +$682,012 $59.27 29
2025 Q4 51,623,774 $3,184,205,678 -$39,122,211 $61.69 352
2025 Q3 50,810,480 $3,171,948,668 -$74,667,802 $62.40 351
2025 Q2 52,028,208 $4,154,947,022 +$68,664,201 $79.85 372
2025 Q1 51,179,850 $4,399,098,887 -$94,834,306 $85.97 354
2024 Q4 52,470,130 $4,096,580,344 +$88,611,492 $78.09 335
2024 Q3 51,041,422 $3,683,307,685 +$3,200,629 $72.10 323
2024 Q2 51,067,584 $3,515,715,953 -$4,889,638 $68.85 305
2024 Q1 51,320,692 $3,722,982,898 +$23,075,777 $72.56 311
2023 Q4 51,115,027 $3,129,318,451 +$6,370,695 $61.22 287
2023 Q3 50,946,303 $2,913,995,592 +$55,643,279 $57.19 279
2023 Q2 49,864,351 $2,965,000,913 -$29,425,137 $59.43 273
2023 Q1 50,365,220 $3,154,009,517 +$46,802,032 $62.63 280
2022 Q4 50,007,293 $3,131,794,375 +$2,107,559 $62.60 286
2022 Q3 50,088,729 $2,496,799,721 -$37,445,090 $49.83 270
2022 Q2 50,591,595 $2,974,240,060 +$45,867,050 $58.80 273
2022 Q1 50,360,901 $2,667,571,389 -$38,075,618 $52.94 269
2021 Q4 50,531,110 $3,065,040,827 -$86,724,122 $60.65 261
2021 Q3 50,742,397 $2,847,713,877 -$66,715,011 $56.11 240
2021 Q2 51,943,459 $2,706,851,067 -$30,851,217 $52.10 219
2021 Q1 52,622,155 $2,319,703,648 +$13,619,119 $44.08 233
2020 Q4 52,481,635 $1,830,396,086 -$33,067,279 $34.87 227
2020 Q3 53,391,500 $1,942,255,015 -$69,442,046 $36.42 233
2020 Q2 55,276,415 $2,075,158,514 +$31,352,635 $37.56 248
2020 Q1 54,484,428 $1,999,030,159 -$232,050,557 $36.68 242
2019 Q4 60,596,165 $2,454,518,932 +$57,809,287 $40.50 223
2019 Q3 60,663,941 $2,104,223,844 -$40,588,561 $34.69 223
2019 Q2 61,882,668 $1,958,581,043 -$77,895,459 $31.68 203
2019 Q1 64,684,131 $1,934,772,034 +$6,356,835 $29.91 212
2018 Q4 64,521,322 $1,992,028,340 -$29,177,570 $30.88 232
2018 Q3 65,339,093 $2,475,707,052 +$46,607,423 $37.89 228
2018 Q2 64,117,028 $2,460,757,189 -$15,816,343 $38.38 227
2018 Q1 64,996,481 $2,191,463,644 +$74,427,877 $33.72 231
2017 Q4 62,251,760 $2,764,599,700 +$158,390,917 $44.41 246
2017 Q3 58,228,273 $2,915,105,853 +$208,610,443 $50.09 237
2017 Q2 53,896,150 $2,846,183,578 +$96,584,892 $52.81 229
2017 Q1 52,703,516 $2,928,351,747 +$403,489,100 $55.56 237
2016 Q4 51,896,999 $2,703,733,392 -$16,514,792 $52.10 234
2016 Q3 52,282,326 $2,521,183,408 -$14,836,402 $48.27 241
2016 Q2 52,469,070 $2,907,447,728 -$24,211,465 $55.40 265
2016 Q1 53,494,813 $2,860,261,135 +$48,532,478 $53.39 255
2015 Q4 53,158,056 $2,735,865,931 +$7,030,794 $51.48 234
2015 Q3 53,012,021 $2,394,078,785 -$5,665,946 $45.16 205
2015 Q2 53,303,783 $2,464,727,142 -$24,046,662 $46.24 202
2015 Q1 53,965,137 $2,313,937,997 -$37,987,787 $42.89 192
2014 Q4 55,190,371 $1,916,059,210 +$23,933,344 $34.72 175
2014 Q3 54,685,532 $1,770,201,461 +$44,252,568 $32.37 174
2014 Q2 53,376,596 $1,807,875,895 +$43,025,450 $33.89 183
2014 Q1 52,192,219 $1,422,261,770 +$11,814,470 $27.25 167